The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Submucosal Injection Agent Market Research Report 2025

Global Submucosal Injection Agent Market Research Report 2025

Publishing Date : Mar, 2025

License Type :

Report Code : 1701253

No of Pages : 85

Ask Your Query

Report Description
Table of Content

Synopsis

Submucosal Injection Agent is a medical device that is an injectable liquid composition intended for use in gastrointestinal endoscopic procedures for submucosal lift of polyps, adenomas, early stage cancers or other gastrointestinal mucosal lesions, prior to removal with a snare or endoscopic device.
It facilitates endoscopic resection procedures during endoscopic examinations in the upper and lower gastrointestinal tract, such as the esophagus, the stomach.

The global Submucosal Injection Agent market was valued at US$ 97.4 million in 2023 and is anticipated to reach US$ 163.5 million by 2030, witnessing a CAGR of 7.7% during the forecast period 2024-2030.

The global top five submucosal injection agent manufacturers include Seikagaku, Ovesco Endoscopy, GI Supply, Cosmo Pharmaceuticals, Boston Scientific, accounting for more than 60% of the market share, of which the largest manufacturer is Seikagaku, with a market share of more than 18%. North America is the most important submucosal injection agent consumer market in the world, with a market share of more than 32%. In terms of type, the market share of syringe type is more than 90%. In the application field, the market share of hospitals has reached more than 60%.

This report aims to provide a comprehensive presentation of the global market for Submucosal Injection Agent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Submucosal Injection Agent.

Report Scope

The Submucosal Injection Agent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Submucosal Injection Agent market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Submucosal Injection Agent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

Seikagaku
Ovesco Endoscopy
GI Supply
Cosmo Pharmaceuticals
Boston Scientific
The Standard
Micro-Tech Endoscopy
EndoClot Plus

Segment by Type

Syringe Type
Ampoule Type

Segment by Application

Hospitals
Ambulatory Surgical Centers
Specialty Clinics

Consumption by Region

North America (United States, Canada)
Europe (Germany, France, U.K., Italy, Russia)
Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
Latin America (Mexico, Brazil, Argentina)
Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Submucosal Injection Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Submucosal Injection Agent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Submucosal Injection Agent Market Overview
1.1 Product Overview and Scope of Submucosal Injection Agent
1.2 Submucosal Injection Agent Segment by Type
1.2.1 Global Submucosal Injection Agent Market Value Comparison by Type (2024-2030)
1.2.2 Syringe Type
1.2.3 Ampoule Type
1.3 Submucosal Injection Agent Segment by Application
1.3.1 Global Submucosal Injection Agent Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Specialty Clinics
1.4 Global Submucosal Injection Agent Market Size Estimates and Forecasts
1.4.1 Global Submucosal Injection Agent Revenue 2019-2030
1.4.2 Global Submucosal Injection Agent Sales 2019-2030
1.4.3 Global Submucosal Injection Agent Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Submucosal Injection Agent Market Competition by Manufacturers
2.1 Global Submucosal Injection Agent Sales Market Share by Manufacturers (2019-2024)
2.2 Global Submucosal Injection Agent Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Submucosal Injection Agent Average Price by Manufacturers (2019-2024)
2.4 Global Submucosal Injection Agent Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Submucosal Injection Agent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Submucosal Injection Agent, Product Type & Application
2.7 Submucosal Injection Agent Market Competitive Situation and Trends
2.7.1 Submucosal Injection Agent Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Submucosal Injection Agent Players Market Share by Revenue
2.7.3 Global Submucosal Injection Agent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Submucosal Injection Agent Retrospective Market Scenario by Region
3.1 Global Submucosal Injection Agent Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Submucosal Injection Agent Global Submucosal Injection Agent Sales by Region: 2019-2030
3.2.1 Global Submucosal Injection Agent Sales by Region: 2019-2024
3.2.2 Global Submucosal Injection Agent Sales by Region: 2025-2030
3.3 Global Submucosal Injection Agent Global Submucosal Injection Agent Revenue by Region: 2019-2030
3.3.1 Global Submucosal Injection Agent Revenue by Region: 2019-2024
3.3.2 Global Submucosal Injection Agent Revenue by Region: 2025-2030
3.4 North America Submucosal Injection Agent Market Facts & Figures by Country
3.4.1 North America Submucosal Injection Agent Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Submucosal Injection Agent Sales by Country (2019-2030)
3.4.3 North America Submucosal Injection Agent Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Submucosal Injection Agent Market Facts & Figures by Country
3.5.1 Europe Submucosal Injection Agent Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Submucosal Injection Agent Sales by Country (2019-2030)
3.5.3 Europe Submucosal Injection Agent Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Submucosal Injection Agent Market Facts & Figures by Country
3.6.1 Asia Pacific Submucosal Injection Agent Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Submucosal Injection Agent Sales by Country (2019-2030)
3.6.3 Asia Pacific Submucosal Injection Agent Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Submucosal Injection Agent Market Facts & Figures by Country
3.7.1 Latin America Submucosal Injection Agent Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Submucosal Injection Agent Sales by Country (2019-2030)
3.7.3 Latin America Submucosal Injection Agent Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Submucosal Injection Agent Market Facts & Figures by Country
3.8.1 Middle East and Africa Submucosal Injection Agent Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Submucosal Injection Agent Sales by Country (2019-2030)
3.8.3 Middle East and Africa Submucosal Injection Agent Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Submucosal Injection Agent Sales by Type (2019-2030)
4.1.1 Global Submucosal Injection Agent Sales by Type (2019-2024)
4.1.2 Global Submucosal Injection Agent Sales by Type (2025-2030)
4.1.3 Global Submucosal Injection Agent Sales Market Share by Type (2019-2030)
4.2 Global Submucosal Injection Agent Revenue by Type (2019-2030)
4.2.1 Global Submucosal Injection Agent Revenue by Type (2019-2024)
4.2.2 Global Submucosal Injection Agent Revenue by Type (2025-2030)
4.2.3 Global Submucosal Injection Agent Revenue Market Share by Type (2019-2030)
4.3 Global Submucosal Injection Agent Price by Type (2019-2030)
5 Segment by Application
5.1 Global Submucosal Injection Agent Sales by Application (2019-2030)
5.1.1 Global Submucosal Injection Agent Sales by Application (2019-2024)
5.1.2 Global Submucosal Injection Agent Sales by Application (2025-2030)
5.1.3 Global Submucosal Injection Agent Sales Market Share by Application (2019-2030)
5.2 Global Submucosal Injection Agent Revenue by Application (2019-2030)
5.2.1 Global Submucosal Injection Agent Revenue by Application (2019-2024)
5.2.2 Global Submucosal Injection Agent Revenue by Application (2025-2030)
5.2.3 Global Submucosal Injection Agent Revenue Market Share by Application (2019-2030)
5.3 Global Submucosal Injection Agent Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Seikagaku
6.1.1 Seikagaku Corporation Information
6.1.2 Seikagaku Description and Business Overview
6.1.3 Seikagaku Submucosal Injection Agent Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Seikagaku Submucosal Injection Agent Product Portfolio
6.1.5 Seikagaku Recent Developments/Updates
6.2 Ovesco Endoscopy
6.2.1 Ovesco Endoscopy Corporation Information
6.2.2 Ovesco Endoscopy Description and Business Overview
6.2.3 Ovesco Endoscopy Submucosal Injection Agent Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Ovesco Endoscopy Submucosal Injection Agent Product Portfolio
6.2.5 Ovesco Endoscopy Recent Developments/Updates
6.3 GI Supply
6.3.1 GI Supply Corporation Information
6.3.2 GI Supply Description and Business Overview
6.3.3 GI Supply Submucosal Injection Agent Sales, Revenue and Gross Margin (2019-2024)
6.3.4 GI Supply Submucosal Injection Agent Product Portfolio
6.3.5 GI Supply Recent Developments/Updates
6.4 Cosmo Pharmaceuticals
6.4.1 Cosmo Pharmaceuticals Corporation Information
6.4.2 Cosmo Pharmaceuticals Description and Business Overview
6.4.3 Cosmo Pharmaceuticals Submucosal Injection Agent Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cosmo Pharmaceuticals Submucosal Injection Agent Product Portfolio
6.4.5 Cosmo Pharmaceuticals Recent Developments/Updates
6.5 Boston Scientific
6.5.1 Boston Scientific Corporation Information
6.5.2 Boston Scientific Description and Business Overview
6.5.3 Boston Scientific Submucosal Injection Agent Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Boston Scientific Submucosal Injection Agent Product Portfolio
6.5.5 Boston Scientific Recent Developments/Updates
6.6 The Standard
6.6.1 The Standard Corporation Information
6.6.2 The Standard Description and Business Overview
6.6.3 The Standard Submucosal Injection Agent Sales, Revenue and Gross Margin (2019-2024)
6.6.4 The Standard Submucosal Injection Agent Product Portfolio
6.6.5 The Standard Recent Developments/Updates
6.7 Micro-Tech Endoscopy
6.6.1 Micro-Tech Endoscopy Corporation Information
6.6.2 Micro-Tech Endoscopy Description and Business Overview
6.6.3 Micro-Tech Endoscopy Submucosal Injection Agent Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Micro-Tech Endoscopy Submucosal Injection Agent Product Portfolio
6.7.5 Micro-Tech Endoscopy Recent Developments/Updates
6.8 EndoClot Plus
6.8.1 EndoClot Plus Corporation Information
6.8.2 EndoClot Plus Description and Business Overview
6.8.3 EndoClot Plus Submucosal Injection Agent Sales, Revenue and Gross Margin (2019-2024)
6.8.4 EndoClot Plus Submucosal Injection Agent Product Portfolio
6.8.5 EndoClot Plus Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Submucosal Injection Agent Industry Chain Analysis
7.2 Submucosal Injection Agent Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Submucosal Injection Agent Production Mode & Process
7.4 Submucosal Injection Agent Sales and Marketing
7.4.1 Submucosal Injection Agent Sales Channels
7.4.2 Submucosal Injection Agent Distributors
7.5 Submucosal Injection Agent Customers
8 Submucosal Injection Agent Market Dynamics
8.1 Submucosal Injection Agent Industry Trends
8.2 Submucosal Injection Agent Market Drivers
8.3 Submucosal Injection Agent Market Challenges
8.4 Submucosal Injection Agent Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business:

Since 2015

Pre Sales Support:

24*7

Post Sales Support:

24*7

Turn Around Time:

Usually 2 Hours

Clients Served:

425 and counting

Clients Assisted:

1750 and counting

Client Types:

Govt Projects, Private Companies, Consultant and Individuals

Payment:

Partners with:

Number of reports:

1,000,000 and counting

Custom Research:

Available

Report Availability:

Global and Regional Reports

Report Delivery Format:

Usually PDF

Security:

Latest Life Science Market Reports

Global Support Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Hospital OT and X-Ray, Cathode Room Doors (Hermetically Sealed Door) Market Research Report 2025

Global Children\'s DHA Market Research Report 2025

Global Marine Derived Drugs Market Research Report 2025

Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Payments Accepted From

Connect with us at

Complete Secure Website

#socialicons>a span { top: 0px; left: -100%; -webkit-transition: all 0.3s ease; -moz-transition: all 0.3s ease-in-out; -o-transition: all 0.3s ease-in-out; -ms-transition: all 0.3s ease-in-out; transition: all 0.3s ease-in-out;} #socialicons>ahover div{left: 0px;}